DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹13,400 Cr | ₹11,786 Cr | ₹10,959 Cr | ₹9,989 Cr | ₹7,598 Cr |
What is the latest Profit & Loss Account Balance ratio of DIVIS LABORATORIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹13,400 Cr |
| Mar2024 | ₹11,786 Cr |
| Mar2023 | ₹10,959 Cr |
| Mar2022 | ₹9,989 Cr |
| Mar2021 | ₹7,598 Cr |
How is Profit & Loss Account Balance of DIVIS LABORATORIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹13,400 Cr | 13.69 | |
| Mar2024 | ₹11,786 Cr | 7.55 | |
| Mar2023 | ₹10,959 Cr | 9.71 | |
| Mar2022 | ₹9,989 Cr | 31.47 | |
| Mar2021 | ₹7,598 Cr | - | |
Compare Profit & Loss Account Balance of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹181,487.8 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| MANKIND PHARMA | ₹104,275.0 Cr | 0% | 5.9% | 4.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.8% |
0.8% |
-1.5% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses